Horacio Astudillo de la Vega, CEO de Nanopharmacia Group, es un especialista en medicina genómica y molecular que ha dedicado años de estudio a la “medicina de precisión”, analizando las células de pacientes con cáncer para determinar tratamientos personalizados a través de la nanotecnología.

Currently, diabetes affects millions of people. According to the International Diabetes Federation (IDF), 531 million people worldwide suffer from this disease, and it is expected that by 2030, the number will increase to 643 million; by 2050, the outlook is bleak as the number is expected to rise to 1.3...  Read more